FDA Grants Full Approval to Paxlovid to Treat COVID-19

THURSDAY, May 25, 2023 (HealthDay News) -- Americans with COVID-19 have been taking Paxlovid since it was approved under emergency use in late 2021. Today, the U.S. Food and Drug Administration granted full approval to the drug.

This approval will allow drugmaker Pfizer to sell the medication at market rate once government supplies are used up.

Originally published on consumer.healthday.com, part of the BLOX Digital Content Exchange.